Black Titan Corp (BTTC) Stock Analysis

$0.280

-0.001 (-0.36%)At close

Loading chart…

High: 0.309
Open: 0.285
VWAP: 0.29
Volume: 92.11K
Mkt Cap: —
Low: 0.280
Amount: 26.67K
EV/EBITDA, TTM: 0.00

Black Titan Corporation is a holding company that operates through its subsidiaries, Titan Pharmaceuticals Inc. (TTNP), and TalenTec Sdn Bhd (TalenTec). TTNP is a pharmaceutical company that was previously developing therapeutics utilizing the proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. ProNeura consists of a small, solid implant made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The resulting product is a solid matrix that is designed to be administered sub-dermally in a brief, outpatient procedure and is removed in a similar manner at the end of the treatment period. TalenTec is a provider of HCM software in Malaysia. It has introduced numerous human capital management (HCM) solutions to that market, such as Oracle PeopleSoft HCM, Oracle PeopleSoft Financials, Sunfish Workplaze HR, DayForce HCM, and MiHCM Cloud, through its holistic, integrated and reliable services.

AI analysis of Black Titan Corp (BTTC)

Sell

Black Titan Corp is not a good buy right now due to its extremely low RSI of 22.133, indicating oversold conditions, and a staggering year-to-date change of -84.69%.

Valuation Metrics

The current forward P/E ratio for Black Titan Corp (BTTC) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued

5Y Average P/E

0.00

Current P/E

0.00

Overvalued

0.00

Undervalued

0.00

Forward EV/EBITDA

Strongly Undervalued

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued

0.00

Undervalued

0.00

Forward P/S

Strongly Undervalued

5Y Average P/S

0.00

Current P/S

0.00

Overvalued

0.00

Undervalued

0.00

Events Timeline

2026-07-21 (ET)